Avail Complimentary Open Access, for Articles submitted by 31st July, 2021
Free Open Access Publication for articles submitted before July 31, 2021.
No page charges will be levied to authors for the publication of their article.
Quick processing and publication of the submitted papers at certain charges.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.
Complete editorial support to the Guest Editors of thematic issues, such as arrangement of peer reviewing of submitted articles, announcing the forthcoming thematic issues on the websites to attract submissions, etc.
The Guest Editor receives a free copy of the printed issue and free online subscription to any three selected Bentham journals.
The corresponding authors will receive a complimentary one-year online subscription to the journal’s volume in which their article is published.
Authors who wish to submit an article to any of Bentham Science Journals are requested to please complete the following online form with the proposed abstract of the article. The abstract of the article will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of the relevant journal who will then inform the author with a decision about submitting the completed article.
Ramón Cacabelos International Center of Neuroscience and Genomic Medicine EuroEspes Biomedical Research Center 15165-Corunna (Spain) Biography
Biography of Ramón Cacabelos
Dr. Ramón Cacabelos is Professor of Genomic Medicine and President of the EuroEspes Biomedical Research Center, Corunna, Spain. He received his M.D. from Oviedo University, Ph.D. from Santiago University, and D.M.Sci. (Psychiatry) from Osaka University Medical School, Osaka, Japan. After a decade at the Department of Psychiatry in Osaka, he returned to Spain and focused his research activity on the genomics and pharmacogenomics of neurodegenerative disorders. He has published over 600 papers and 24 books, is Editor-in-Chief of the first World Guide for Drug Use and Pharmacogenomics, and is President of the World Association of Genomic Medicine.